|
Real-time Estimate
Cboe BZX
13:02:36 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 14.42 USD | +0.03% |
|
-10.24% | - |
| 10-22 | Pharma sector doubles down on AI to slash costs, timelines | RE |
| 10-20 | Drug developer Lycia Therapeutics targets $938 million valuation in US IPO | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.03% | -10.24% | - | - | - | - | - | - | - | 683M | |
| -3.10% | -3.43% | -12.88% | +13.18% | +56.09% | +36.29% | +67.69% | +1.93% | - | 65.28B | |
| +0.33% | +0.33% | -7.32% | -0.89% | +9.21% | +10.16% | +78.07% | +225.62% | +5,451.77% | 54.57B | |
| +0.16% | +1.73% | +8.83% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| -1.09% | +2.09% | +0.92% | +28.25% | +21.31% | +25.76% | +51.97% | +7.53% | +279.26% | 45.03B | |
| -2.12% | -5.55% | -1.04% | +11.44% | +19.54% | +15.13% | +113.07% | -1.12% | +1,006.89% | 42.17B | |
| +1.33% | -5.38% | -7.81% | -1.11% | +133.50% | +220.71% | +899.36% | +574.08% | - | 39.42B | |
| -0.74% | -4.84% | +6.31% | +6.19% | +9.41% | +14.53% | +44.45% | +3.10% | +154.40% | 32.71B | |
| -2.70% | -7.34% | -15.74% | +14.22% | +42.05% | +23.17% | +0.36% | -62.78% | - | 24.01B | |
| +1.11% | +15.18% | +30.19% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.5B | |
| -0.29% | -5.05% | -12.63% | -4.97% | -9.07% | -18.37% | -5.08% | -68.95% | - | 21.82B | |
| +0.69% | -1.64% | -20.03% | -10.15% | -45.93% | -42.63% | +294.05% | +256.44% | +583.87% | 20.38B | |
| +0.08% | +8.57% | +9.71% | +14.66% | +20.32% | +13.29% | +170.00% | +220.87% | +2,251.29% | 18.93B | |
| -0.09% | +13.18% | +21.20% | +59.18% | +78.98% | +82.83% | +106.87% | -16.98% | +366.83% | 17.06B | |
| -0.58% | +8.20% | +8.59% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.69B | |
| -0.11% | +1.03% | +11.45% | +16.57% | +48.43% | +62.68% | +222.05% | +205.42% | +495.74% | 16.13B | |
| +0.02% | +4.51% | +6.46% | -3.36% | - | - | - | - | - | 16.1B | |
| +2.59% | +1.28% | +3.03% | +4.85% | +180.86% | +162.43% | +375.61% | +1,411.75% | +779.81% | 14.75B | |
| -0.94% | +4.94% | +4.12% | +8.31% | +0.32% | +0.42% | -22.32% | -35.12% | +127.14% | 14.18B | |
| -5.62% | +0.27% | -2.96% | -11.83% | +15.55% | +3.56% | +512.43% | - | - | 14.63B | |
| Average | -0.55% | +3.29% | +1.60% | +12.79% | +37.98% | +39.94% | +174.71% | +158.39% | +925.12% | 27.73B | |
| Weighted average by Cap. | -0.69% | +2.91% | -0.17% | +12.59% | +36.57% | +39.21% | +163.84% | +122.64% | +1,233.34% |
- Stock Market
- Stocks
- IAM Stock
- Sector Iambic Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
